Abiopharma

🔍 Lerner Neil (Executive)

Company: Compass Therapeutics, Inc. (CMPX)

Report Date: 2026-01-02

Detailed Transactions and Holdings:

• Acquired 62,500 shares of Common Stock at $5.17 per share (Direct)
  Date: 2026-01-02 | Code: A | equity_swap_involved: 0 | shares_owned_after: 382,500.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 435,000 shares of Stock Option (Right to Buy) at $5.17 per share (Derivative)
  Date: 2026-01-02 | Code: A | Expires: 2036-01-02 | equity_swap_involved: 0 | shares_owned_after: 435,000.00 | transaction_form_type: 4 | Footnotes: F3

Footnotes:

• F1: Represents restricted stock units ("RSU") granted on January 2, 2026. Each RSU represents a contingent right to receive one share of common stock. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first vesting on January 2, 2027.
• F2: 62,500 of the shares represents unvested restricted stock units ("RSU") granted on January 2, 2026. Each RSU represents a contingent right to receive one share of common stock. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first installment vested on January 2, 2027.
• F3: The options vest over 48 substantially equal monthly installments starting February 2, 2026.